Summary of "Erratum."
Erratum Murthy et al., "The synthetic GLP-I receptor agonist, exenatide, reduces intimal hyperplasia in insulin resistant rats" Diabetes & Vascular Disease Research 2010 7(2):138-144. In the above paper the Acknowledgments section was printed incorrectly. It should have read: Acknowledgements Supported by Lilly - Amylin and, in part, by NIH grants HL62000, and HL77421. Dr Fonseca is also supported by NIH clinical trials (ACCORD and TINSAL-T2D) and by a grant from the American Diabetes Association and the Tullis Tulane Alumni Chair in Diabetes.
This article was published in the following journal.
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20647246
- DOI: http://dx.doi.org/10.1177/1479164110379072
[This corrects the article DOI: 10.1017/jns.2013.31.].
[This corrects the article on p. 1831 in vol. 6, PMID: 25589983.].
[This corrects the article on p. 74 in vol. 6, PMID: 24605219.].
This erratum amends the missing part in acknowledgment section of our publication [Opt. Express 22, A606 (2014)].
During the type-setting of the final version of the article  some of the additional files were swapped, and several were completely replaced. The correct files are republished in this Erratum.
Medical and Biotech [MESH] Definitions
Work consisting of an acknowledgment of an error, issued by a publisher, editor, or author. It customarily cites the source where the error occurred, giving complete bibliographic data for retrieval. In the case of books and monographs, author, title, imprint, paging, and other helpful references will be given; in the case of journal articles, the author, title, paging, and journal reference will be shown. An erratum notice is variously cited as Errata or Corrigenda.